NCT06152523 2026-04-06
MONAMI
Assistance Publique - Hôpitaux de Paris
Phase 2 Withdrawn
Clinical Trials
151 trialsNCT07222358 2026-04-06
Multi-component Remote Assessment in Adult Survivors Using a Connected Technology Platform for Healthcare Delivery
St. Jude Children's Research Hospital
Withdrawn
NCT06922825 2026-01-21
Pilot Study Evaluating Tumor Microenvironment Interaction in Solid Tumor Patients
Vanderbilt-Ingram Cancer Center
Phase EARLY_PHASE1 Withdrawn
NCT06967987 2026-01-21
BEMAFLOT
Institut Cancerologie de l'Ouest
Phase 2 Withdrawn
NCT07293520 2025-12-26
Improving Consent Experiences in Clinical Trials
Washington University School of Medicine
Phase NA Withdrawn
NCT04020029 2025-12-19
Leveraging Mindsets to Improve Health and Wellbeing in Patients With Cancer
Stanford University
Phase NA Withdrawn
NCT04036045 2025-10-06
Approaches to Identify Early Biomarkers and Pathogenesis of Anthracycline Cardiotoxicity
Connecticut Children's Medical Center
Withdrawn
NCT04372641 2025-09-17
Testing the Safety of CB-5339 in Patients With Cancer
National Cancer Institute (NCI)
Phase 1 Withdrawn
NCT06762808 2025-08-15
Phase II Study of Atezolizumab and Tiragolumab With ctDNA for HPV-positive SCC
M.D. Anderson Cancer Center
Phase 2 Withdrawn
NCT05052632 2025-08-13
Evaluating a New Gonadotoxic Risk Stratification System
University of Colorado, Denver
Withdrawn
NCT05000905 2025-08-06
Improving Cognition and Behavior in Pediatric Cancer Survivors Using a Novel Mindful Attention Training
University of California, San Francisco
Phase NA Withdrawn
NCT06161558 2025-07-16
Erlotinib in Combination With Select Tyrosine Kinase Inhibitors in Adult Patients With Advanced Solid Tumors
National Institutes of Health Clinical Center (CC)
Phase 1 Withdrawn
NCT05257707 2025-07-09
MOCA
Centre Hospitalier Universitaire de Besancon
Phase NA Withdrawn
NCT05222308 2025-07-08
Advanced Planning for Online Accounts and Data
University of Colorado, Denver
Phase NA Withdrawn
NCT06416436 2025-06-29
Dose-escalation Study of Ultra-high Dose Ablative Radiosurgery With Immunotherapy for Bulky Metastatic Cancer Patients
University of Kansas Medical Center
Phase 1 Withdrawn
NCT06390657 2025-05-11
S-C-PATHY
EBG MedAustron GmbH
Withdrawn
NCT02591433 2025-05-01
JeffQuit Group Therapy Program for Smoking Cessation in Patients With a History of Cancer
Thomas Jefferson University
Phase NA Withdrawn
NCT06395090 2025-04-08
MK-9999-01B
Merck Sharp & Dohme LLC
Phase 1/2 Withdrawn
NCT05828303 2025-04-01
A Phase 1 Study to Evaluate the Potential Drug Interactions Between Repotrectinib and Metformin, Digoxin, and Rosuvastatin in Patients With Advanced Solid Tumors
Turning Point Therapeutics, Inc.
Phase 1 Withdrawn
NCT06365918 2025-02-17
Study of VG2025 Delivered Intraperitoneally in Patients With Advanced Solid Tumors With Carcinomatosis
M.D. Anderson Cancer Center
Phase 1 Withdrawn
NCT04271436 2025-01-07
Immune Checkpoint Blockade Therapy Using 18F-FLT PET/CT
Washington University School of Medicine
Phase 2 Withdrawn
NCT05653661 2025-01-07
Nab-Paclitaxel/STI-3031 Complex (AP160-Complex) for the Treatment of Advanced or Metastatic Solid Tumors
Mayo Clinic
Phase 1 Withdrawn
NCT06537063 2025-01-07
Detection of G-quadruplex DNA Methylation in Cancer
Zhongnan Hospital
Withdrawn
NCT06654258 2024-11-26
Supporting Spiritual Wellbeing in Young Adults With Cancer Using a Digital Health Approach: A Feasibility Study
Wake Forest University Health Sciences
Phase NA Withdrawn
NCT06023368 2024-11-14
Reducing Port Access Pain and Clinic Wait Time: An Evaluation of EMLA Cream Versus nüm™ Vapocoolant Spray
University of Kentucky
Phase 4 Withdrawn
NCT06377202 2024-11-07
Long-Term Follow-Up Safety Study of Subjects Treated with SynKIR-110 in Cancer Studies
Verismo Therapeutics
Withdrawn
NCT05589857 2024-10-23
A Phase II Randomized Controlled Trial to Determine the Efficacy of an auGmented reAlity gaMe in pediatrIc caNcer Patients Who Are Opioid Tolerant Users Undergoing Surgery to Reduce Post-operative Opioid Use
M.D. Anderson Cancer Center
Phase 2 Withdrawn
NCT04135326 2024-10-09
Transcranial Direct Current Stimulation in Reducing Pain in Cancer Patients With Chemotherapy Induced Peripheral Neuropathy
M.D. Anderson Cancer Center
Phase EARLY_PHASE1 Withdrawn
NCT03003195 2024-09-03
The P10s-PADRE Basket Trial: Vaccination of Metastatic Cancer Patients
University of Arkansas
Phase 2 Withdrawn
NCT05112458 2024-08-15
Cope 360 App for Caregivers of Children With Cancer
Indiana University
Phase NA Withdrawn
NCT04023240 2024-08-12
68-Ga-FAPI PET Imaging in Malignancy
Stanford University
Phase 2 Withdrawn
NCT05423808 2024-08-12
GerOnTe-TWOBE
Universitaire Ziekenhuizen KU Leuven
Phase NA Withdrawn
NCT05408195 2024-06-28
ONCO-CHATBOT
University Hospital, Toulouse
Phase NA Withdrawn
NCT03044795 2024-05-03
REPAIR
University Medical Center Groningen
Phase 2 Withdrawn
NCT05678283 2024-04-17
A Study of Absorption, Metabolism, and Elimination CC-90010 in Participants With Advanced Solid Tumors
Bristol-Myers Squibb
Phase 1 Withdrawn
NCT04294875 2024-03-06
MPT0B64
J Ints Bio
Phase EARLY_PHASE1 Withdrawn
NCT05312307 2024-02-26
StrataEXPress
Strata Oncology
Withdrawn
NCT03668769 2024-02-23
Quitting Schedule Mobile Smartphone Application in Helping Participants to Quit Smoking
M.D. Anderson Cancer Center
Phase NA Withdrawn
NCT05248425 2024-02-08
ME-Q
University Health Network, Toronto
Phase NA Withdrawn
NCT03671720 2024-02-07
Personalized Vaccine Generated by Autologous Dendritic Cells Pulsed With Autologous Whole Tumor Cell Lysate Treat Advanced Solid Tumor Patients With High Tumor Mutation Burden
Capital Medical University
Phase EARLY_PHASE1 Withdrawn
NCT05153447 2024-01-09
M-Tech
University of Rochester
Phase NA Withdrawn
NCT02356822 2023-12-05
Sarah Cannon Outcomes Registry
SCRI Development Innovations, LLC
Withdrawn
NCT02458040 2023-11-28
Clinical Benefit of Genetic Biomarkers for Guiding Treatment Decisions in Oncology Drugs
Assistance Publique - Hôpitaux de Paris
Withdrawn
NCT03341364 2023-10-24
Acceptance and Commitment Based Group Therapy for Cancer Patients
Region Skane
Phase NA Withdrawn
NCT05728372 2023-10-10
64Cu-DOTA Pembrolizumab for Imaging Metastatic Solid Tumors in Patients Receiving Stereotactic Body Radiation
City of Hope Medical Center
Phase EARLY_PHASE1 Withdrawn
NCT01632436 2023-10-02
Hepatic
CTI BioPharma
Phase 1 Withdrawn
NCT05431439 2023-09-29
Omics of Cancer: OncoGenomics
National Institutes of Health Clinical Center (CC)
Withdrawn
NCT05828277 2023-09-26
A Phase 1 Study to Assess the Effect of Hepatic Impairment on the Pharmacokinetics of Repotrectinib in Advanced Cancer Patients
Turning Point Therapeutics, Inc.
Phase 1 Withdrawn
NCT05729139 2023-08-09
Cemiplimab/Peg-Interferon-α in Advanced CSCC
Baptist Health South Florida
Phase 1 Withdrawn
NCT04210726 2023-07-27
Effect of Salt Solution Immersion Bath on Cancer in Vivo.
Batroussy, Rafik
Phase NA Withdrawn